September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Sphingosine-1-Phosphate demonstrates anti-angiogenic and anti-inflammatory properties
Author Affiliations & Notes
  • Carolina Franco Nitta
    Surgery, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
    Surgery, NMVA Health Care System, Albuquerque, New Mexico, United States
  • Finny Monickaraj
    Surgery, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Sampathkumar Rangasamy
    Translational Genomics Research Institute, Phoenix, Arizona, United States
  • Paul McGuire
    Cell Biology and Physiology, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
  • Arup Das
    Surgery, University of New Mexico Health Sciences Center, Albuquerque, New Mexico, United States
    Surgery, NMVA Health Care System, Albuquerque, New Mexico, United States
  • Footnotes
    Commercial Relationships   Carolina Franco Nitta, None; Finny Monickaraj, None; Sampathkumar Rangasamy, None; Paul McGuire, None; Arup Das, None
  • Footnotes
    Support  VA Merit Review Grant entitled: "Sphingosine-1-Phosphate: A Novel Target in Early Diabetic Retinopathy".
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 3209. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Carolina Franco Nitta, Finny Monickaraj, Sampathkumar Rangasamy, Paul McGuire, Arup Das; Sphingosine-1-Phosphate demonstrates anti-angiogenic and anti-inflammatory properties. Invest. Ophthalmol. Vis. Sci. 2016;57(12):3209.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Inflammation and angiogenesis can have negative effects on the integrity of the blood-retinal barrier in diabetic retinopathy. We have previously shown that in animal models of diabetic retinopathy there are significantly lower levels of sphingosine-1-phosphate (S1P). Also we demonstrated increased tight junction protein expression of the endothelium with purified S1P. We hypothesize that pericyte-derived S1P also plays a role in maintenance of the endothelium in an anti-inflammatory and anti-angiogenic state.

Methods : Human retinal endothelial cells (HREC) were incubated in high (30.5mM) and normal (5.5mM) glucose for 7 days. Leukocyte adhesion assay on treated HREC was done using fluorescently-labelled U937 macrophages. Changes in ICAM-1 and EphrinB2 mRNA in endothelial cells were examined using TaqMan real time PCR. Additionally, HREC were incubated in media with or without purified S1P for 16 hours, and EphrinB2 and Angiopoietin-2 mRNAs were analyzed. Trans-endothelial resistance changes in HREC treated with S1P were measured by Electric-Cell Substrate Impedance (ECIS).

Results : Incubation of retinal endothelial cell monolayers in high glucose for 7 days enhanced the adhesion of U937 to the cell surface compared to low glucose incubated cells. This increased adhesion was likely facilitated in part by the increased expression of the cell adhesion molecule ICAM-1 and the anti-angiogenic factor, EphrinB2. In contrast, treatment of HREC with S1P leads to the down regulation of EphrinB2 as well as the pro-inflammatory mediator angiopoietin-2, concomitant with tightening of the endothelial cell barrier.

Conclusions : We conclude that pericyte-derived S1P can exert anti-angiogenic and anti-inflammatory roles, which may be key for its potential benefit in the maintenance of the blood-retinal barrier in diabetic retinopathy.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×